How Second-Line Injectable Drugs Work

Clin Infect Dis. 2021 Jun 15;72(12):e1167-e1168. doi: 10.1093/cid/ciaa1874.

Authors

Armand Van Deun¹, Tom Decroo^{2

3}

Affiliations

¹ Independent Consultant, Leuven, Belgium.
² Institute of Tropical Medicine, Unit of HIV and TB, Department of Clinical Sciences, Antwerp, Belgium.
³ Research Foundation Flanders, Brussels, Belgium.

PMID: 33341871
DOI: 10.1093/cid/ciaa1874

No abstract available

Publication types

Letter
Comment

MeSH terms

Aminoglycosides
Antitubercular Agents
Capreomycin
Humans
Pharmaceutical Preparations*
Tuberculosis, Multidrug-Resistant*

Substances

Aminoglycosides
Antitubercular Agents
Pharmaceutical Preparations
Capreomycin